During the past decade, Presence Saint Mary's Hospital conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 58 clinical trials were completed, i.e. on average, 223.1% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 34 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Presence Saint Mary's Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 57 trials, followed by "SWOG Cancer Research Network" with 13 trials sponsored, "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "NSABP Foundation Inc" with 4 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Presence Saint Mary's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 30 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "NCIC Clinical Trials Group" with 4 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Presence Saint Mary's Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Recurrent Breast Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Stage IV Breast Cancer AJCC v6 and v7" (5 trials) and "Breast Adenocarcinoma" (4 trials). Many other conditions were trialed in "Presence Saint Mary's Hospital" in a lesser frequency.

Most popular intervention types in "Presence Saint Mary's Hospital" are "Drug" (74 trials), "Other" (69 trials), "Biological" (43 trials), "Procedure" (16 trials) and "Radiation" (10 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (55 trials), "Quality-of-Life Assessment" (20 trials), "Bevacizumab" (15 trials), "Paclitaxel" (12 trials) and "Cisplatin" (11 trials). Other intervention names were less common.

The vast majority of trials in "Presence Saint Mary's Hospital" are 71 trials for "All" genders, 14 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Presence Saint Mary's Hospital". undefined are not yet recruiting, 4 are recruiting, 53 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Presence Saint Mary's Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Presence Saint Mary's Hospital, 2 "Phase 1" clinical trials were conducted, 31 "Phase 2" clinical trials and 57 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Presence Saint Mary's Hospital has several departments that took part in Clinical trials: "Alexian Brothers Neurosciences Institute" - 41 trials, "Alexian Brothers Radiation Oncology" - 14 trials, "Cardiovascular Associates" - 5 trials, "AMITA Health Cancer Institute & Outpatient Center" - 3 trials, "Elgin Cardiology Associates" - 3 trials